project id: TCGA-UVM; case submitter id: TCGA-V4-A9F5; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.05; rna integrity number: 8.8; age at index: 85; days to birth: -31314; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1928; age at diagnosis: 31314; ajcc clinical m: M1b; ajcc clinical n: N0; ajcc clinical stage: Stage IV; ajcc clinical t: T4e; ajcc pathologic m: M1b; ajcc pathologic n: N0; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4e; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 203.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 289; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-V4-A9F5-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 98.0; percent tumor nuclei: 96.0;